About InSilicoTrials
InSilicoTrials is a Healthcare company based in Milan (Italy) founded in 2016. Healthcare simulation services are provided for medical applications worldwide. InSilicoTrials has raised $3.5 million across 2 funding rounds from investors including United Ventures, Pi Campus and UniCredit Start Lab. InSilicoTrials offers products and services including Simulation Platform and Computational Models. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Pharmacometrics.
Company details
InSilicoTrials was established in 2016 in Milan, Italy, within the healthcare technology sector. Simulation services are offered to model clinical trials and drug development processes using computational methods. Operations center on in silico approaches to assist pharmaceutical and biotech firms in reducing experimental needs. The companys domain, insilicotrials.com, supports its digital platform for service delivery across Europe and beyond.
- Headquarters Milan, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website insilicotrials.com
- Social LinkedIn
- Total Equity Funding$3.5M (USD)
in 2 rounds
- Latest Funding Round$3.5M (USD), Series A
Jul 2020
- InvestorsUnited Ventures
& 2 more
Products & Services of InSilicoTrials
InSilicoTrials offers a comprehensive portfolio of products and services, including Simulation Platform and Computational Models.
Cloud platform for AI-based drug development simulations
Tools integrating models to reduce R&D costs and time
Funding Insights of InSilicoTrials
InSilicoTrials has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.5M
- Total Rounds 2
- Last Round Series A — $3.5M
- Investors Count 3
All 2 funding rounds of InSilicoTrials with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $3.5M | Series A | – | United Ventures | |
| Jun 2020 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in InSilicoTrials
InSilicoTrials has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include United Ventures, Pi Campus and UniCredit Start Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed toward early-growth SaaS and digital companies. | unitedventures.com | Milan, Italy | ||
Early-stage AI startups are funded and supported by Pi Campus. | picampus.it | Rome, Italy | ||
| unicreditstartlab.eu |
Investor details for InSilicoTrials
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of InSilicoTrials
9 people are tracked at InSilicoTrials (6 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Vincenzo Carbone, PhD | Head Of R&i | Leadership |
Luca Emili | CEO | Leadership |
Mario Torchia | Chief Operating Officer | Leadership |
Roberta Bursi, PhD, PMP | Chief Scientific Officer | Leadership |
Matteo Gazzin | Head Of Engineering | Leadership |
Daniel Röshammar | Vice President Of Research & Development | Leadership |
Emanuele Pertosi | Administrative Officer | Team |
Michael Eckstut | Senior Advisor | Team |
Niccolò Totis | Senior Pharmacometrician | Team |
Complete people profiles for InSilicoTrials
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of InSilicoTrials
3 dated milestones of InSilicoTrials across 4 years, from founding to its latest funding, stage changes and deals.
- Founded InSilicoTrials is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $3.5M.
Web traffic of InSilicoTrials
The website of InSilicoTrials (insilicotrials.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▼ 42.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insilicotrials
Complete news archive for InSilicoTrials
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InSilicoTrials
InSilicoTrials was founded in 2016 and raised its 1st funding round 4 years after it was founded.
InSilicoTrials is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
InSilicoTrials is a funded company, having raised a total of $3.5M across 2 funding rounds to date.
InSilicoTrials was established in 2016 in Milan, Italy, within the healthcare technology sector. Simulation services are offered to model clinical trials and drug development processes using computational methods. Operations center on in silico approaches to assist pharmaceutical and biotech firms in reducing experimental needs. The companys domain, insilicotrials.com, supports its digital platform for service delivery across Europe and beyond.
InSilicoTrials offers Simulation Platform and Computational Models.
InSilicoTrials has 3 investors. Key investors include United Ventures, Pi Campus, and UniCredit Start Lab.